ARA Content
?>
Download eBooks and Software
 100 Healthy Raw Snacks And Treats
Healthy, Natural, Sugar Free, No Cook Recipes. Living Nutrition For Living Bodies. Learn How Simple It Is To Improve Your Health With These 100 Quick And Easy Recipes
Moving And Living In Spain
Get 50% Payout! Everything You Need To Know About Moving And Living In Spain. From Property Buying, Health Care, Immigration,permits,tax,language,finding Work. Expats Guide For Your Life Under The Spanish Sun. Get Tools Here: www.spain-tips.com/affiliate
Chocolate Recipe Guilt Free
Attention Affiliates. This Ebook Is Hugely Popular Within The Raw, Health Food Niche Converting Over 11% When Book Reviewed In Newsletter Or Emailed Direct To Your List. Good Info, Natural Ingredients, 70 + Original, Healthy, Raw Chocolate Recipes, Photos
Articles > Health-Saving Pediatric Drug Becomes Readily Available to Those in Need
by: ARA Content
(ARA) - We can all sympathize with the frustration people experience waiting for a new drug that is being tested for a certain disorder. Imagine you have a child with a rare disorder and the only drug effective for treating the disorder is not only extremely hard to obtain, but available only through a nationally-administered random selection process. For many American families, this dilemma is a harsh reality.
Patients suffering from a host of difficult to treat orphan disorders have found marked relief from using HP Acthar Gel. Some disorders Acthar helps include seizure complex in babies and young children, referred to as West's syndrome or infantile spasm; Still's disease and ulcerative colitis; Bell's palsy; multiple sclerosis; adrenocortical insufficiency and non-endocrine disorders that are responsive to glucocorticoids.
For the past four years, however, the drug has only been available through a limited access program administered by the National Organization for Rare Disorders (NORD), a federation of more that 135 non-profit health organizations serving people with rare disorders.
U.S. physicians who were interested in obtaining Acthar Gel for their patients with life-threatening or severely debilitating conditions who did not respond to any other treatment were given first access to the drug. Others with "non-life-threatening" cases had to enroll in a computerized random selection process administered by NORD.
An estimated 1,600 patients, primarily suffering from West's syndrome and multiple sclerosis who experience episodes of "flare," have been allowed access to HP Acthar Gel each year for the past four years under the limited access program. More than 5,000 additional patients whose physicians requested the drug were denied.
The origins of this drug shortage crisis date back to 1996 when Aventis Pharmaceuticals stopped making Acthar for a few months because of manufacturing difficulties.
But now, Questcor Pharmaceuticals, Inc. (AMEX: QSC) has signed an agreement with Aventis to acquire the worldwide rights to HP Acthar Gel. Questcor has also reached a manufacturing agreement with Aventis and will gradually move production to an independent manufacturing facility.
As a result, HP Acthar Gel is now back in full production and is returning to normal levels of distribution. Questcor began shipments of HP Acthar Gel to wholesalers the last week of September 2001, giving patients in need access to the product.
"We are delighted that Questcor is making this critically important product more widely available after this long period of restricted distribution," said Abbey S. Meyers, president of NORD. "We have been working closely with the company over the last several months to ensure that anyone with a need for Acthar Gel is now able to readily receive the product through more traditional channels. Too many people have suffered as a result of limited access to Acthar Gel."
Questcor Pharmaceuticals, Inc. is a fully integrated specialty pharmaceutical company that serves the needs of acute and critical care hospitals with its proprietary products. Visit www.questcor.com for more information on the company and its products.
If you are a patient with a disorder that can be treated with Acthar, ask your doctor to contact Questcor Pharmaceuticals at (510) 400-0700. For more information about Acthar, including distribution information, please visit www.Acthar.com.
?>
News on Health
Health Net Announces Appearance at Sanford C. Bernstein’s 28th Strategic Decisions Conference
Health Net, Inc. today announced that members of its management team are scheduled to present at Sanford C. Bernstein’s 28th Strategic Decisions Conference on May 30, 2012, at approximately 9:00 a.m. Health Highlights: May 25, 2012
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Health Highlights: May 24, 2012
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Extend Health Bringing 500+ Jobs to Richardson, Texas
Extend Health, Inc., a leading provider of health benefit management services, including the nation’s largest private Medicare exchange, today celebrated the opening of the first of two new service centers in Richardson, Texas, that together expect to bring more than 500 new jobs to the greater Dallas–Fort Worth area. Everyday Health Expands Sales Organization & Integrated Offerings
NEW YORK, May 25, 2012 /PRNewswire/ -- Everyday Health, Inc., the leading provider of online health solutions for consumers, professionals and marketers, expands its sales organization with the promotions ...
|
